Tranzactioneaza Voyager Therapeutics (US.VYGR) - 1.73 USD (%) Tranzactioneaza
Indici
Descriere companie
Voyager Therapeutics, Inc. (https://www.voyagertherapeutics.com/) is a clinical-stage gene therapy company that is focused on developing treatments for patients suffering from severe neurological diseases. The Company's pipeline consists of programs for severe neurological indications, including Huntington’s disease; a monogenic form of amyotrophic lateral sclerosis (ALS); and tau-related diseases including Alzheimer’s disease, frontotemporal dementia (FTD) and progressive supranuclear palsy (PSP). Its pipeline is also focused on advancing gene therapies that leverage AAV capsids (TRACER) and vectorized antibodies. It is focused on identifying AAV capsids, which are the outer viral protein shells that enclose the genetic material of the virus payload. The Company is developing vectorized antibodies, including vectorized antibody compounds, which consist of a virus vector genome that encodes approximately one or more antibodies that target and bind to a tau protein.